Cite
HARVARD Citation
Beier, J. et al. (2017). Efficacy, safety, and tolerability of once‐daily abediterol in patients with stable, persistent asthma: a Phase II, randomized, 7‐day, crossover study. Pharmacology research & perspectives. 5 (5), p. n/a. [Online].